Skip to content

Application of Continuous Glucose Monitoring for Early Risk Prediction of Gestational Diabetes Mellitus

Construction and Application of an Integrated Blood Glucose Management Platform for Early Risk Prediction of Gestational Diabetes Mellitus Using Artificial Intelligence and Continuous Glucose Monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107288
Enrollment
Unknown
Registered
2025-08-07
Start date
2025-08-08
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

Sponsors

Sichuan Provincial Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-45 years 2. Gestational age of = 13 weeks 3. Singleton pregnancy 4. Plan to take regular prenatal examinations during the whole pregnancy and deliver at recruitment and research settings 5. Willing to comply with the study follow-up schedule and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. With preexisting Type 1 diabetes or Type 2 diabetes before the study 2. With fasting plasma glucose =7.0 mmol/L or 75 g glucose OGTT determination of plasma glucose =11.1 mmol/L for 2 hours, or with HbA1c =6.5% during pregnancy. 3. Have serious skin conditions (eg. allergies, eczema) that precludes wearing the sensor for 15 days 4. With chronic preexisting serious conditions including cancer, cardiac insufficiency, hepatic or kidney dysfunction, psychosis, or any other serious comorbidities 5. Take glucose-lowering medications or steroids that affect blood glucose levels at enrollment 6. For whom continuation of pregnancy is medically contraindicated, or any other individual determined by the investigators to be unsuitable for study enrolment.

Design outcomes

Primary

MeasureTime frame
IADPSG (International Association of Diabetes and Pregnancy Study Groups)-defined Gestational Diabetes Mellitus (GDM);

Secondary

MeasureTime frame
Pregnancy outcome;

Countries

China

Contacts

Public ContactLiu Jing

Sichuan Provincial Women's and Children's Hospital

liujspmch@163.com+86 186 1819 9498

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026